ClinicalTrials.Veeva

Menu

Research on the Value of Genomics Research Based on Ultrasound Endoscopic Biopsy in the Differential Diagnosis and Prognostic Evaluation of Pancreatic Occupancy

N

Naval Military Medical University

Status

Unknown

Conditions

Pancreatic Space Occupying

Study type

Observational

Funder types

Other

Identifiers

NCT04986215
2021-PC-Maker(V1.1)

Details and patient eligibility

About

To clarify the value of genomic testing in the clinical diagnosis or prognosis of pancreatic space occupation, provide a basis for the selection of clinical diagnosis methods for pancreatic space occupation, optimize clinical management strategies, and improve the prognosis of patients.

Enrollment

300 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age 18-85, no gender limit
  2. Imaging examinations suggest that the clear pancreas has clear space-occupying lesions
  3. Admitted to our department, ready to undergo endoscopic ultrasound biopsy to confirm the diagnosis

Exclusion criteria

  1. There are contraindications for endoscopic ultrasound biopsy
  2. Failed to join the group or refused follow-up due to various reasons

Trial design

300 participants in 2 patient groups

Benign pancreatic space occupying group
Malignant pancreatic space occupying group

Trial contacts and locations

1

Loading...

Central trial contact

Xiangyu Kong, associate professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems